Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,636.7
26.5 (1.02%)

 

  • STI Straits Times Index
    2,636.7
    26.5 (1.02%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,536.3
    21.9 (1.44%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,124.2
    697.0 (2.85%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,090.6
    64.6 (2.13%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,146.0
    24.2 (0.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,966.8
    52.4 (1.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,559.7M
  • Value: 1,083.5M
  • Rise: 238
  • Fall: 120
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
BlackGoldNatural0.020+0.008
Singapore-eDev0.116+0.002
Medtecs Intl0.465+0.055
Jadason0.033+0.002
Broadway Ind0.124+0.008
Rex Intl0.180-0.001
Oceanus^0.007-
NetLink NBN Tr0.960-0.015
New Wave0.012+0.005
Sino Grandness0.024-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ANATARA LIFESCIENCES LTD ANATARA LIFESCIENCES
Updated on 01 Jul 2020 (End of trading day)
Last (AUD): 0.130 Change: - High: 0.130 Remarks: -
Change (%): - Low: 0.130
Open 0.130 Yesterday's Close 0.13
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.05753 Trailing EPS (AUD) e -0.05316 NAV (AUD) b 0.0856
PE a - Trailing PE f - Price / NAV b 1.5187
Dividend (AUD) d - Cash In Hand (AUD) g 0.0762 Issued & Paid-up Shares c 49,856,200
Dividend Yield (%) d - Price / Cash In Hand g 1.706 Treasury Shares h -
Beta - 75 Daysi 0.671 R-Squared - 75 Days(%)i 0.30 Market Cap (M) 6.481
Beta - 500 Daysi 0.405 R-Squared - 500 Days (%)i 0.27 Enterprise Value (M) 2.181
Piotroski F Score 3 Exchange Code ANR Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 82.81 Free Float (%) 99.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Jan 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ANATARA LIFESCIENCES LTD ASX 6.481 - - 1.5187 -
Industry Biotechnology ASX 3,544.356 57.178 51.784 13.6854 0.894
Local Peer CSL ASX 129,131.536 48.131 44.577 14.9313 0.933
Local Peer MESOBLAST LTD ASX 1,927.094 - - 2.4179 -
Local Peer POLYNOVO LIMITED ASX 1,732.051 - - 70.6199 -
Local Peer TELIX PHARMACEUTIC ASX 379.349 - - 5.4127 -
Local Peer NEXT SCIENCE LTD ASX 240.550 - - 8.6999 -
Local Peer ALTERITY THERAPEUTICS LIMITED ASX 171.164 - - 15.2778 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 143.222 - - 10.3410 -
Local Peer IMUGENE LIMITED ASX 141.631 - - 2.1769 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 87.750 - - - -
Local Peer IMMUTEP LTD ASX 78.021 - - 2.7826 -
Local Peer CYNATA THERAPEUTICS LTD ASX 73.788 - - 7.5812 -
Local Peer BIOTRON ASX 55.453 - - 6.5833 -
Other Local Peers KAZIA THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), MEMPHASYS LTD (ASX), BIONOMICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANTEOTECH LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), LEAF RESOURCES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 150,073.575 19.137 19.554 15.8222 2.286
Global Peer GILEAD SCIENCES INC NASDAQ 95,407.382 17.714 19.228 4.3235 3.344
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer VERTEX PHARMACEUTICAL NASDAQ 74,225.820 63.074 49.126 11.4871 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 68,545.008 32.397 30.073 5.6495 -
Global Peer ILLUMINA INC NASDAQ 54,176.850 54.069 57.513 11.6886 -
Global Peer BIOGEN INC NASDAQ 43,207.022 7.338 7.350 3.4436 -
Global Peer SEATTLE GENETICS INC NASDAQ 28,998.047 - - 16.4237 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,206.341 25.403 39.834 5.7060 0.745
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,818.747 10.323 10.454 2.1126 -
Other Global Peers MODERNA INC (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), NOVAVAX INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), Lonza (SGX), AMICUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GENSCRIPT BIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), 3SBIO (HKEx), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALPHAMAB-B (HKEx), TWIST BIOSCIENCE CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VIVA BIOTECH (HKEx), EDITAS MEDICINE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VAXCYTE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MACROGENICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), HAOHAI BIOTEC (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VERACYTE INC (NASDAQ), ARVINAS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), SANGAMO THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), COMPUGEN (NASDAQ), TRANSLATE BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), KADMON HLDGS INC (NYSE), STOKE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KINTOR PHARMA-B (HKEx), BELLUS HEALTH INC (NASDAQ), AKOUOS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AGENUS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AVROBIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ARDELYX INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), SYNDAX PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), ASCLETIS-B (HKEx), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), HARPOON THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), PROTHENA CORP PLC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KAMADA (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AFFIMED N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), LEE'S PHARM (HKEx), PROQR THERAPEUTICS N V (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), DPHARMA (Bursa), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), MEDICINOVA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), XOMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), CHIASMA INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PFENEX INC (NYSE American), IBIO INC (NYSE American), SURFACE ONCOLOGY INC (NASDAQ), ARAVIVE INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMV INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), LUMOS PHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), UNI-BIO GROUP (HKEx), OTONOMY INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SESEN BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ORGANOVO HLDGS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), HEAT BIOLOGICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), COHBAR INC (NASDAQ), SYNLOGIC INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), AXOVANT GENE THERAPIES LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VACCINEX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EQUILLIUM INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CT ENTERPRISE (HKEx), BIONANO GENOMICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ORAGENICS INC (NYSE American), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOSINO BIO-TEC (HKEx), BIOCARDIA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), REGENT PACIFIC (HKEx), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), Suntar Eco-City (SGX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), PRECIPIO INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), UNUM THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HAO WEN HLDGS (HKEx), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-3.70 %
10 Days --0.040
-23.53 %
20 Days --0.040
-23.53 %
Medium Term Return 3 Months --0.030
-18.75 %
6 Months --0.110
-45.83 %
1 Year --0.160
-55.17 %
Long Term Return 2 Years --0.450
-77.59 %
3 Years --0.870
-87.00 %
5 Years --0.720
-84.71 %
Annualised Return Annualised --
-31.31 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.130 - 0.450 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High -0.320 % Change From 1 Year High (%) -71.11
2 Years Range 0.130 - 0.875 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High -0.745 % Change From 2 Years High (%) -85.14
5 Years Range 0.130 - 1.830 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -1.700 % Change From 5 Years High (%) -92.90
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. It also develops and commercializes Detach, a non-antibiotic therapy that prevents and treats diarrhea in piglets. The company was founded by Tracey Mynott on July 15, 2010 and is headquartered in Brisbane, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
01 Jul 2020 0.130 0.130 0.130 0.130 - -
30 Jun 2020 0.135 0.150 0.130 0.130 89,105 -
29 Jun 2020 0.160 0.160 0.160 0.160 5,000 -
26 Jun 2020 0.140 0.160 0.140 0.160 94,241 -
25 Jun 2020 0.140 0.140 0.130 0.130 61,538 -
24 Jun 2020 0.135 0.135 0.135 0.135 14,920 -
23 Jun 2020 0.150 0.160 0.135 0.150 105,870 -
22 Jun 2020 0.150 0.165 0.150 0.155 81,435 -
19 Jun 2020 0.175 0.180 0.150 0.165 60,955 -
18 Jun 2020 0.180 0.180 0.165 0.170 54,000 -
17 Jun 2020 0.175 0.180 0.170 0.170 23,313 -
16 Jun 2020 0.180 0.180 0.170 0.175 74,000 -
15 Jun 2020 0.185 0.185 0.185 0.185 6,000 -
12 Jun 2020 0.180 0.185 0.180 0.185 25,604 -
11 Jun 2020 0.185 0.185 0.185 0.185 20,000 -
10 Jun 2020 0.190 0.190 0.190 0.190 1,250 -
09 Jun 2020 0.190 0.190 0.190 0.190 15,684 -
05 Jun 2020 0.180 0.180 0.180 0.180 121 -
04 Jun 2020 0.180 0.190 0.180 0.190 19,800 -
03 Jun 2020 0.170 0.185 0.170 0.170 21,913 -
02 Jun 2020 0.190 0.190 0.190 0.190 - -
01 Jun 2020 0.190 0.190 0.190 0.190 10,000 -
Summary
Current 2 Weeks
(18 Jun 2020 to 01 Jul 2020)
0.180 0.180 0.130 0.130 567,064 -
Previous 2 Weeks
(03 Jun 2020 to 17 Jun 2020)
0.170 0.185 0.130 0.170 207,685 -
4 Weeks from
(06 May 2020 to 02 Jun 2020)
0.195 0.205 0.130 0.190 412,226 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.